These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31727246)

  • 1. Distinguishing perforin-mediated lysis and granzyme-dependent apoptosis.
    Rudd-Schmidt JA; Trapani JA; Voskoboinik I
    Methods Enzymol; 2019; 629():291-306. PubMed ID: 31727246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack.
    Lopez JA; Susanto O; Jenkins MR; Lukoyanova N; Sutton VR; Law RH; Johnston A; Bird CH; Bird PI; Whisstock JC; Trapani JA; Saibil HR; Voskoboinik I
    Blood; 2013 Apr; 121(14):2659-68. PubMed ID: 23377437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perforin: structure, function, and role in human immunopathology.
    Voskoboinik I; Dunstone MA; Baran K; Whisstock JC; Trapani JA
    Immunol Rev; 2010 May; 235(1):35-54. PubMed ID: 20536554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrahepatic lymphocyte expression of dipeptidyl peptidase I-processed granzyme B and perforin induces hepatocyte expression of serine proteinase inhibitor 6 (Serpinb9/SPI-6).
    Stout-Delgado HW; Getachew Y; Miller BC; Thiele DL
    J Immunol; 2007 Nov; 179(10):6561-7. PubMed ID: 17982045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular basis for perforin oligomerization and transmembrane pore assembly.
    Baran K; Dunstone M; Chia J; Ciccone A; Browne KA; Clarke CJ; Lukoyanova N; Saibil H; Whisstock JC; Voskoboinik I; Trapani JA
    Immunity; 2009 May; 30(5):684-95. PubMed ID: 19446473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target cell apoptosis induced by cytotoxic T cells and natural killer cells involves synergy between the pore-forming protein, perforin, and the serine protease, granzyme B.
    Trapani JA
    Aust N Z J Med; 1995 Dec; 25(6):793-9. PubMed ID: 8770355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perforin and granzymes: function, dysfunction and human pathology.
    Voskoboinik I; Whisstock JC; Trapani JA
    Nat Rev Immunol; 2015 Jun; 15(6):388-400. PubMed ID: 25998963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of multiple granzymes by cytotoxic T lymphocyte implies that they activate diverse apoptotic pathways in target cells.
    Zhou F
    Int Rev Immunol; 2010; 29(1):38-55. PubMed ID: 20100081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serglycin determines secretory granule repertoire and regulates natural killer cell and cytotoxic T lymphocyte cytotoxicity.
    Sutton VR; Brennan AJ; Ellis S; Danne J; Thia K; Jenkins MR; Voskoboinik I; Pejler G; Johnstone RW; Andrews DM; Trapani JA
    FEBS J; 2016 Mar; 283(5):947-61. PubMed ID: 26756195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orphan granzymes find a home.
    Bovenschen N; Kummer JA
    Immunol Rev; 2010 May; 235(1):117-27. PubMed ID: 20536559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perforin-A key (shaped) weapon in the immunological arsenal.
    Spicer BA; Conroy PJ; Law RHP; Voskoboinik I; Whisstock JC
    Semin Cell Dev Biol; 2017 Dec; 72():117-123. PubMed ID: 28757431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killer lymphocytes use granulysin, perforin and granzymes to kill intracellular parasites.
    Dotiwala F; Mulik S; Polidoro RB; Ansara JA; Burleigh BA; Walch M; Gazzinelli RT; Lieberman J
    Nat Med; 2016 Feb; 22(2):210-6. PubMed ID: 26752517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design Parameters for Granzyme-Mediated Cytotoxic Lymphocyte Target-Cell Killing and Specificity.
    Woodsworth DJ; Dunsing V; Coombs D
    Biophys J; 2015 Aug; 109(3):477-88. PubMed ID: 26244730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A method for detecting intracellular perforin in mouse lymphocytes.
    Brennan AJ; House IG; Oliaro J; Ramsbottom KM; Hagn M; Yagita H; Trapani JA; Voskoboinik I
    J Immunol; 2014 Dec; 193(11):5744-50. PubMed ID: 25348626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time detection of CTL function reveals distinct patterns of caspase activation mediated by Fas versus granzyme B.
    Li J; Figueira SK; Vrazo AC; Binkowski BF; Butler BL; Tabata Y; Filipovich A; Jordan MB; Risma KA
    J Immunol; 2014 Jul; 193(2):519-28. PubMed ID: 24928990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The battlefield of perforin/granzyme cell death pathways.
    Hoves S; Trapani JA; Voskoboinik I
    J Leukoc Biol; 2010 Feb; 87(2):237-43. PubMed ID: 19915166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perforin and the granule exocytosis cytotoxicity pathway.
    Catalfamo M; Henkart PA
    Curr Opin Immunol; 2003 Oct; 15(5):522-7. PubMed ID: 14499260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional significance of the perforin/granzyme cell death pathway.
    Trapani JA; Smyth MJ
    Nat Rev Immunol; 2002 Oct; 2(10):735-47. PubMed ID: 12360212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granzyme C supports efficient CTL-mediated killing late in primary alloimmune responses.
    Getachew Y; Stout-Delgado H; Miller BC; Thiele DL
    J Immunol; 2008 Dec; 181(11):7810-7. PubMed ID: 19017970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the cytotoxic response mediated by perforin and granzyme B in patients with non-Hodgkin lymphoma.
    Souza BMB; De Vito FB; Calado ML; Silva MV; Oliveira LR; Rodrigues-Júnior V; Moraes-Souza H
    Leuk Lymphoma; 2018 Jan; 59(1):214-220. PubMed ID: 28679297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.